China Handheld Coagulometer PT/Inr Blood Coagulation Analyzer Poct, Find details about China Medical, Clinical from Handheld Coagulometer PT/Inr Blood Coagulation Analyzer Poct
Clinical application:
HemoPOC® - A portable coagulometer, coupled with disposable PT-INR test strips, yields immediate results for the quantative testing of prothrombin time, allowing patients undergoing oral anticoagulation therapy with Warfarin to monitor their International Normalized Ratio (INR) using a finger-prick blood test at the point of care.
HemoPOC® has proven to be highly accurate through clinical trial. During May 2018 and Jan 2019, a comparative study was conducted between HemoPOC and laboratory coagulation tests, and the result showed consistency rate of 99%. In the left figure, among a total of 101 data points, the INR value of 100 points ranges from 1.0 to 4.0, and one point reaches 5.3. The slope of linear regression is 1.00, the intercept is 0.05, and R = 0.940. In the right figure, only one point is beyond the guideline range, and the other 100 points are within the guideline range. That is to say, the anastomosis rate is 99%.
Benefits:Place of Origin | China |
Guangdong | |
Brand Name | HemoPOC |
Model Number | HGINR-1 |
Instrument classification | Class I |
Warranty | 1 Year |
After-sale Service | Online technical support |
Product name | HemoPOC coagulometer |
Operational Conditions Temperature | 10°C - 30°C |
Humidity | 10%RH- 90%RH |
Coagulometer | -25°C ~ +50°C |
Measuring Range INR | 0.7~8.0 |
Precision CV | <5% |
Weight | 156 g (excluding battries) |
Size | 40*35*32 cm |
MOQ | 1 Pc |
Packaging | Standard export corrugated paper board cartons or wooden box |
Pallet | Plastic/ Wooden pallet |
Shipping | By sea/ By air/ By courier (DHL, FEDEX, UPS, TNT) |
About Creative Biosciences (Guangzhou) Co., Ltd.
CreativeBio was founded in January 2015. It has evolved an advanced bio-tech enterprise specializing in noninvasive cancer detection kits (including device, reagent, and equipment) and POCT products. Colosafe® is a featured IVD product which has been implemented in over 500 major top hospitals covering almost all provincial areas in China by far. As a leading benchmark company in the industry with world class R&D team, CreativeBio has engaged early detection kits for lung, bladder, cervical, liver cancers and other POCT products actively in the development to enrich its pipelines of which some will be ready for market in the next couple years.